KMK Consulting is now a part of Tredence Inc Read more here.

KMK at ISPOR 2025

We’re excited to continue pushing boundaries and contributing to advancements in health and well-being!

We had a fantastic time at ISPOR 2025!

We were proud to contribute research to our client Teva Pharmaceuticals’ poster, “Gleaning Novel Insights from Real-World Data: A Machine-Learning Guided Analytical Framework,” which was a Top 5% Finalist for the ISPOR 2025 Research Presentation Awards. It was exciting to see it presented on Monday, May 6th.

The conference itself was a valuable learning experience. It offered a wealth of insights into the latest methodologies, data analytics, and evidence-based approaches driving transformative changes in health and well-being. Attendees delved into advancements in cost-effectiveness analysis, real-world evidence, AI in HEOR methods, patient-centered research, and health equity. The conference fostered valuable interdisciplinary discussions, bringing together economists, healthcare professionals, policymakers, and industry leaders to collaborate and share knowledge.

Overall, ISPOR 2025 was a resounding success.

Highlights ISPOR 2025

Representing the team at ISPOR 2025

sonam_shah

Sonam Shah

Director

joshzheng

Zhishui Zheng

Associate Director

rose_kmk

Rose Zhang

Associate Manager

jennifer_kmk

Jennifer Friderici

Senior Biostatistician/Associate Director

yulin_kmk

Yulin Shi

Senior Associate